These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4790563)

  • 1. Relative incidence of phlebitis caused by continuous intravenous infusion of cephapirin and cephalothin.
    Lane AZ; Taggart JG; Iles RL
    Antimicrob Agents Chemother; 1972 Sep; 2(3):234-5. PubMed ID: 4790563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phlebitis associated with cephalosporins: cephapirin versus cephalothin.
    Inagaki J; Bodey GP
    Curr Ther Res Clin Exp; 1973 Feb; 15(2):37-43. PubMed ID: 4632504
    [No Abstract]   [Full Text] [Related]  

  • 3. Phlebitis associated with the intravenous use of cephalothin and cephapirin.
    Sorrentino AP; Haughey EJ; Cronin DW; Bohen LN
    Am J Hosp Pharm; 1976 Jul; 33(7):642-4. PubMed ID: 941915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative incidence of phlebitis due to buffered cephalothin, cephapirin, and cefamandole.
    Berger S; Ernst EC; Barza M
    Antimicrob Agents Chemother; 1976 Apr; 9(4):575-9. PubMed ID: 5053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of side effects of intravenous cephapirin and cephalothin with special reference to the incidence of phlebitis].
    Watanabe A; Oizumi K; Konno K
    Jpn J Antibiot; 1983 Dec; 36(12):3395-8. PubMed ID: 6674550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phlebitis associated with the intravenous use of cephapirin and cephalothin in the combination therapy of antibiotics.
    Meguro S; Kuraishi Y; Kobayashi T; Chinen T; Ikeda K; Nagata T; Ichiba K; Abe M
    Jpn J Antibiot; 1980 Nov; 33(11):1163-5. PubMed ID: 7241794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of phlebitis produced by cephapirin and cephalothin.
    Cross AS; Tramont EC
    Antimicrob Agents Chemother; 1976 Apr; 9(4):722-4. PubMed ID: 1267443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind controlled comparison of phlebitis produced by cephapirin and cephalothin.
    Carrizosa J; Levison ME; Kaye D
    Antimicrob Agents Chemother; 1973 Feb; 3(2):306-7. PubMed ID: 4597719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cephapirin.
    Med Lett Drugs Ther; 1974 Jun; 16(13):53-4. PubMed ID: 4842601
    [No Abstract]   [Full Text] [Related]  

  • 10. Adverse reactions to cephalothin and cephapirin. Uniform occurrence on prolonged intravenous administration of high doses.
    Sanders WE; Johnson JE; Taggart JG
    N Engl J Med; 1974 Feb; 290(8):424-9. PubMed ID: 4811017
    [No Abstract]   [Full Text] [Related]  

  • 11. Double-blind comparison of phlebitis associated with cefazolin and cephalothin.
    Cole DR
    Int J Clin Pharmacol Biopharm; 1976 Jul; 14(1):75-7. PubMed ID: 789268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind comparison of phlebitis produced by cefazolin versus cephalothin.
    Shemonsky NK; Carrizosa JC; Kaye D; Levison ME
    Antimicrob Agents Chemother; 1975 Apr; 7(4):481-2. PubMed ID: 1147583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind study to investigate methods to prevent cephalothin-induced phlebitis.
    Maddox RR; Rush DR; Rapp RP; Foster TS; Mazella V; McKean HE
    Am J Hosp Pharm; 1977 Jan; 34(1):29-34. PubMed ID: 831472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of thrombophlebitis associated with three cephalosporin antibiotics.
    Siebert WT; Westerman EL; Smilack JD; Bradshaw MW; Williams TW
    Antimicrob Agents Chemother; 1976 Sep; 10(3):467-9. PubMed ID: 791101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of buffering on the incidence and severity of cephalothin-induced phlebitis.
    Lipman AG
    Am J Hosp Pharm; 1974 Mar; 31(3):266-8. PubMed ID: 4819440
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of a new cephalosporin antibiotic, cephapirin.
    Wiesner P; MacGregor R; Bear D; Berman S; Holmes K; Turck M
    Antimicrob Agents Chemother; 1972 Apr; 1(4):303-9. PubMed ID: 4208896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cephapirin: pharmacology in normal human volunteers.
    Axelrod J; Meyers BR; Hirschman SZ
    J Clin Pharmacol New Drugs; 1972; 12(2):84-8. PubMed ID: 4550606
    [No Abstract]   [Full Text] [Related]  

  • 18. Significant reduction in the incidence of phlebitis with buffered versus unbuffered cephalothin.
    Bergeron MG; Brusch JL; Barza M; Weinstein L
    Antimicrob Agents Chemother; 1976 Apr; 9(4):646-8. PubMed ID: 1267438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and in vitro evaluation of cephapirin, a new cephalosporin antibiotic.
    Bran JL; Levison ME; Kaye D
    Antimicrob Agents Chemother; 1972 Jan; 1(1):35-40. PubMed ID: 4596741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential inactivation of cephapirin vs. cephalothin by penicillin-resistant strains of Staphylococcus aureus: a preliminary study.
    Wilkins J; Leedom JM; Overturf GD; Baraff LJ
    J Infect Dis; 1978 Apr; 137(4):494-7. PubMed ID: 649993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.